Back to top
more

DaVita (DVA)

(Delayed Data from NYSE)

$161.97 USD

161.97
575,208

+1.87 (1.17%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $161.95 -0.02 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 6% (16 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Veradigm (MDRX)-FDB Vela to Enhance Pharmacy Connectivity

Veradigm's (MDRX) latest progress with FDB Vela is likely to offer prescribers and patients greater choice and cost transparency.

Here's Why You Should Retain Teleflex (TFX) Stock for Now

Investors are optimistic about Teleflex (TFX), led by growth in Vascular, Interventional and Surgical businesses.

Three Reasons to Add PacBio (PACB) Stock to Your Portfolio

PacBio's (PACB) product development activities raise optimism about the stock.

OPKO Health (OPK) Gets BARDA Contract to Combat Antibody Threats

OPKO Health's (OPK) latest awarded funding is likely to enable the development of novel multispecific antibodies against viral infectious disease threats.

Quest Diagnostics (DGX) to Boost Lab Services With New Pact

Quest Diagnostics (DGX) latest deal will boost dialysis laboratory testing and reduce the laboratory costs of dialysis programs for ESRD patients.

3 Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio

Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.

AngioDynamics (ANGO) Q1 Earnings and Revenues Top Estimates

AngioDynamics (ANGO) registers strong revenue growth in the Med Tech business in first-quarter fiscal 2024.

Here's Why You Should Buy Globus Medical (GMED) Stock Now

Investors are optimistic about Globus Medical (GMED) on growing musculoskeletal devices demand and strong industry prospects.

LabCorp (LH) to Expand Diagnostics Services With New Deal

LabCorp's (LH) recent deal will bring together critical expertise, experience and technology from both organizations to improve the delivery of high-quality patient care.

Veradigm (MDRX) Advances Tie-Up to Enhance Care Delivery

Veradigm's (MDRX) new phase of strategic investment is likely to drive innovation and close the evidence gap in behavioral health.

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA vs. CHE: Which Stock Is the Better Value Option?

Here's Why You Should Invest in Neogen (NEOG) Stock Now

Investors are optimistic about Neogen (NEOG), led by progress in the Food Safety business and recent product launches.

Medtronic (MDT) to Launch Academic R&D Grants With New Pact

Medtronic's (MDT) partnership will enable teachers to improve their skill set, boosting student opportunities to pursue STEM careers in corporate America.

Accuray's (ARAY) New Offering to Boost Radiation Treatment Plans

Accuray's (ARAY) latest offering is likely to improve radiation treatment.

Should Value Investors Buy Quest Diagnostics (DGX) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Here's Why You Should Retain Zimmer Biomet (ZBH) for Now

Investors are optimistic about Zimmer Biomet (ZBH) on business recovery and expansion in emerging markets.

Veradigm's (MDRX) New Tie-Up to Boost Patients' Health Outcomes

Veradigm's (MDRX) latest partnership is likely to promote value-based care initiatives for healthcare providers and the patients they serve.

Shaun Pruitt headshot

Top Medical Stocks to Buy Amid Market Volatility

While there is no guarantee that medical stocks will offer a hedge against market volatility, healthcare is essential even during economic uncertainty.

Here's Why You Should Retain Ecolab (ECL) Stock for Now

Ecolab's (ECL) strength in its business raises optimism about the stock.

Here's Why You Should Retain Medtronic (MDT) Stock for Now

Investors are optimistic about Medtronic (MDT) on strong global expansion.

Derek Lewis headshot

Buy These 3 Low-Beta Stocks to Navigate Volatility

Adding low-beta stocks can be a great way to counter volatility, as these stocks are less sensitive to the market's overall movements

3 Reasons to Hold Catalent (CTLT) Stock in Your Portfolio

Catalent's (CTLT) product and service launches and a slew of strategic deals raise optimism about the stock.

Here's Why You Should Invest in Penumbra (PEN) Stock for Now

Investors are optimistic about Penumbra (PEN), driven by growth in vascular and neuro businesses.

Here's Why Investors Should Retain Omnicell (OMCL) Stock Now

Investors are optimistic about Omnicell (OMCL), led by its digital transformation strategy.

Here's Why You Should Retain Inspire Medical (INSP) Stock Now

Inspire Medical's (INSP) focus on R&D raises optimism about the stock.